Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
Recursion (Nasdaq: RXRX) announced that CEO & President Najat Khan, Ph.D. will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Recursion (Nasdaq: RXRX) announced that CEO & President Najat Khan, Ph.D. will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 10:30am PT in San Francisco.
Management will also participate in the 28th Annual Needham Growth Conference on Friday, January 16, 2026. Webcasts will be available in the events section of Recursion Investor Relations at ir.recursion.com.
Details
News Market Reaction – RXRX
On Jan 6, the day this news came out, RXRX closed 4.12% above the previous close.
Data tracked by StockTitan Argus for the Jan 6 session.
Key Figures
- Conference date
- January 13, 2026
- J.P. Morgan Healthcare Conference presentation
- Presentation time
- 10:30am PT
- J.P. Morgan Healthcare Conference slot
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Needham conference
- 28th Annual
- Needham Growth Conference participation
- Share price
- $4.37
- Pre-news current price for RXRX
- 52-week range
- $3.79 – $12.36
- 52-week low and high for RXRX
- Market cap
- $2,185,920,261
- Pre-news market capitalization
- Price vs 52-week high
- -64.64%
- Distance from 52-week high before this news
Historical Context
-
Positive REC-4881 TUPELO Phase 1b/2 efficacy and safety data in FAP.
-
Announcement of webinar for upcoming REC-4881 TUPELO clinical readout.
-
Q3 2025 results with lower revenue and large net loss, business update.
-
Board‑approved CEO transition effective January 1, 2026.
-
Announcement of participation in two November 2025 investor conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13, 10:30am PT at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
Management will also participate in the following upcoming investor conference:
- 28th Annual Needham Growth Conference - Friday, January 16, 2026
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.recursion.com, or connect on X and LinkedIn.
Investor Contact investor@recursion.com Media Contact media@recursion.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.